{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:34:27Z","timestamp":1781530467981,"version":"3.54.1"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.humpath.2017.09.018","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T06:30:14Z","timestamp":1510122614000},"page":"198-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor-infiltrating T lymphocytes and morphogenesis of follicular lymphoma\u2014reply"],"prefix":"10.1016","volume":"72","author":[{"given":"Luc","family":"Xerri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Huet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2017.09.018_bb0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.humpath.2017.03.023","article-title":"Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients","volume":"64","author":"Xerri","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2017.09.018_bb0010","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1008791","article-title":"Understanding high endothelial venules: lessons for cancer immunology","volume":"4","author":"Ager","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.humpath.2017.09.018_bb0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1078-0432.154.11.1","article-title":"Increased vascularization predicts favorable outcome in follicular lymphoma","volume":"11","author":"Koster","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2017.09.018_bb0020","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3324\/haematol.2009.021766","article-title":"Vascularization predicts overall survival and risk of transformation in follicular lymphoma","volume":"95","author":"Farinha","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2017.09.018_bb0025","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1182\/blood-2009-11-253260","article-title":"Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment","volume":"115","author":"Clear","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2017.09.018_bb0030","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1158\/1078-0432.CCR-14-3253","article-title":"The prognostic impact of CD163-positive macrophages in follicular lymphoma: a study from the BC Cancer Agency and the Lymphoma Study Association","volume":"21","author":"Kridel","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717304057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717304057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T18:30:17Z","timestamp":1659810617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817717304057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":6,"alternative-id":["S0046817717304057"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2017.09.018","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-infiltrating T lymphocytes and morphogenesis of follicular lymphoma\u2014reply","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2017.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2017.09.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}